Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Molecular & Cellular Oncology|December 3, 2021
KMT2D deficiency confers a therapeutic vulnerability to glycolytic and IGFR inhibitors in melanomaNavya Murugesan, Mayinuer Maitituoheti
Bioinformatics (Oxford, England)|October 31, 2015
EMDomics: a robust and powerful method for the identification of genes differentially expressed between heterogeneous classesSheida Nabavi, Daniel Schmolze, Mayinuer Maitituoheti, et al.
Journal of Visualized Experiments : Jove|April 24, 2018
An Integrated Platform for Genome-wide Mapping of Chromatin States Using High-throughput ChIP-sequencing in Tumor TissuesChristopher Terranova, Ming Tang, Elias Orouji, et al.
Oncology Letters|June 20, 2014
Twist2 contributes to cisplatin-resistance of ovarian cancer through the AKT/GSK-3β signaling pathwayTian Wang, Yan Li, Abidan Tuerhanjiang, et al.
Reproductive Biomedicine Online|November 27, 2012
Association of an oestrogen receptor gene polymorphism in Chinese Han women with endometriosis and endometriosis-related infertilityWenwen Wang, Yan Li, Mayinuer Maitituoheti, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 10, 2011
Adeno-associated virus-mediated local delivery of LIGHT suppresses tumorigenesis in a murine cervical cancer modelMayinuer Maitituoheti, Yan Li, Wenwen Wang, et al.
Nature Communications|March 30, 2019
Atypical plant homeodomain of UBR7 functions as an H2BK120Ub ligase and breast tumor suppressorSantanu Adhikary, Deepavali Chakravarti, Christopher Terranova, et al.
Cancer Cell|April 4, 2020
KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung CancerHunain Alam, Ming Tang, Mayinuer Maitituoheti, et al.
Cell Reports|July 21, 2021
Reprogramming of bivalent chromatin states in NRAS mutant melanoma suggests PRC2 inhibition as a therapeutic strategyChristopher J Terranova, Ming Tang, Mayinuer Maitituoheti, et al.
Pageof 2